VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-76 Cr | ₹-7.21 Cr | ₹-51 Cr | ₹-17 Cr | ₹56 Cr |
What is the latest Cash Flow from Investing Activities ratio of VENUS REMEDIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-76 Cr |
| Mar2024 | ₹-7.21 Cr |
| Mar2023 | ₹-51 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹56 Cr |
How is Cash Flow from Investing Activities of VENUS REMEDIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-76 Cr | Negative | |
| Mar2024 | ₹-7.21 Cr | Negative | |
| Mar2023 | ₹-51 Cr | Negative | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹56 Cr | - | |
Compare Cash Flow from Investing Activities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,223.5 Cr | -6.7% | -9.6% | 207.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.9% | 12.8% | 4.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 3.2% | 14% | 13.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | 0.7% | 5.5% | 36.9% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 6.8% | 18.8% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 0.7% | 5.5% | 9.4% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -6.7% |
-9.6% |
207.4% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses